EVALUATION OF LUNG FUNCTION AND BIOMARKERS IN THE MONITORING AND CONTROL OF BRONCHIAL ASTHMA

Abstract

Bronchial asthma is a chronic inflammatory disease of the airways that requires continuous monitoring for proper control. This article reviews the importance of pulmonary function assessment, with an emphasis on spirometry, and the role of biomarkers such as exhaled nitric oxide (FeNO) and blood eosinophils in asthma management. Spirometry is highlighted as essential for the diagnosis and follow-up of the disease, although it has limitations in detecting subclinical inflammation. Biomarkers and complementary tests, such as impulse oscillometry, are explored as additional tools for a more personalized and effective approach to asthma management. The integration of these technologies can improve asthma control and patients' quality of life.